Hanying Bao, PhD
Shanghai YingLi Pharmaceutical Co. Ltd.
4
0
0
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
shun lu, MD
Shanghai Chest Hospital
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Agostino Tafuri
AOU Sant'Andrea
Shared therapeutic areas:
Laura Nocilli
Ospedale Papardo
Shared therapeutic areas:
Vincenzo Fraticelli
Responsible Research Hospital
Shared therapeutic areas:
Roberta Murru
Ospedale Oncologico" A. Businco" - ARNAS "G. Brotzu"
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Luca Laurenti
Policlinico Universitario Gemelli IRCCS
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Caterina Cecilia Stelitano
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors
First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies
A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors
All 4 trials loaded